We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HALO icon
176
Halozyme
HALO
$12.5B
$2.62M 0.05%
68,543
-10,000
-13% -$410K
2022 Q1
6 quarters
AGIO icon
177
Agios Pharmaceuticals
AGIO
$1.9B
$2.6M 0.05%
105,221
+39,000
+59% +$1.03M
2022 Q4
3 quarters
APLE icon
178
Apple Hospitality REIT
APLE
$3.85B
$2.58M 0.05%
+168,242
New +$2.57M
2023 Q3
0 quarters
DSAQ icon
179
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$2.55M 0.05%
232,911
– –
2021 Q4
7 quarters
KDK icon
180
Kodiak AI
KDK
$351M
$2.54M 0.05%
247,522
– –
2023 Q2
1 quarter
LIN icon
181
Linde
LIN
$223B
$2.53M 0.05%
6,800
-8,200
-55% -$3.12M
2023 Q2
1 quarter
RCFA icon
182
DELISTED
Perception Capital Corp. IV
RCFA
$2.53M 0.05%
231,102
– –
2022 Q1
6 quarters
SZZL icon
183
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$2.52M 0.04%
231,102
– –
2022 Q1
6 quarters
CSTA
184
DELISTED
Constellation Acquisition Corp I
CSTA
$2.52M 0.04%
233,367
– –
2021 Q1
10 quarters
INSP icon
185
Inspire Medical Systems
INSP
$2.03B
$2.49M 0.04%
12,571
+4,300
+52% +$1.08M
2022 Q3
4 quarters
TLGY icon
186
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
$2.49M 0.04%
226,579
– –
2022 Q1
6 quarters
VEEA
187
Veea Inc
VEEA
$14.7M
$2.49M 0.04%
11,555
– –
2021 Q2
9 quarters
IVCB icon
188
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$2.47M 0.04%
226,579
– –
2022 Q1
6 quarters
BFAC icon
189
DELISTED
Battery Future Acquisition Corp.
BFAC
$2.47M 0.04%
226,579
– –
2022 Q2
5 quarters
FEXD icon
190
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$2.46M 0.04%
231,102
– –
2022 Q1
6 quarters
BPMC icon
191
DELISTED
Blueprint Medicines
BPMC
$2.46M 0.04%
48,984
+1,200
+3% +$64.1K
2022 Q4
3 quarters
CPT icon
192
Camden Property Trust
CPT
$11.3B
$2.45M 0.04%
25,932
-67,737
-72% -$7.2M
2022 Q2
5 quarters
SEDA icon
193
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$2.45M 0.04%
231,102
– –
2022 Q1
6 quarters
TGVC
194
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$2.44M 0.04%
226,579
– –
2021 Q4
7 quarters
VERA icon
195
Vera Therapeutics
VERA
$2.12B
$2.44M 0.04%
177,991
+50,000
+39% +$858K
2023 Q1
2 quarters
MITA icon
196
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$2.44M 0.04%
231,102
– –
2021 Q3
8 quarters
PRLH icon
197
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$2.43M 0.04%
226,579
– –
2022 Q2
5 quarters
EONR icon
198
EON Resources
EONR
$26.5M
$2.43M 0.04%
222,542
– –
2022 Q2
5 quarters
CSLM icon
199
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$2.42M 0.04%
226,579
– –
2022 Q1
6 quarters
ENER
200
DELISTED
Accretion Acquisition Corp
ENER
$2.42M 0.04%
231,102
– –
2021 Q4
7 quarters

Similar funds

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.